PharmaCorp Rx Inc. (TSXV:PCRX)

PharmaCorp Rx Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	24.01	25.89	12.89	2.24	2.73	0.98
Cash & Short-Term Investments	24.01	25.89	12.89	2.24	2.73	0.98
Cash Growth	151.10%	100.87%	474.84%	-17.99%	178.91%	-
Receivables	1.59	1.22	0.33	-	-	-
Inventory	3.13	2.71	1.31	-	-	-
Prepaid Expenses	0.14	0.08	0.05	-	-	-
Other Current Assets	-	-	-	0.08	-	0.02
Total Current Assets	28.87	29.89	14.57	2.32	2.73	1
Property, Plant & Equipment	5.4	5.48	4.02	-	-	-
Goodwill	18.61	18.6	11.48	-	-	-
Other Intangible Assets	11.46	11.6	5.13	-	-	-
Total Assets	64.34	65.57	35.21	2.32	2.73	1

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.38	5.2	1.54	0.05	0.02	0.03
Current Portion of Long-Term Debt	0.39	0.39	0.08	-	-	-
Current Portion of Leases	0.15	0.15	0.07	-	-	-
Current Income Taxes Payable	-	0.06	0.01	-	-	-
Total Current Liabilities	3.92	5.81	1.7	0.05	0.02	0.03
Long-Term Debt	3.05	3.09	0.32	-	-	-
Long-Term Leases	0.83	0.91	0.49	-	-	-
Long-Term Deferred Tax Liabilities	3.37	3.49	2.14	-	-	-
Total Liabilities	11.18	13.3	4.64	0.05	0.02	0.03

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	50.95	50.95	31.7	2.8	2.74	1
Additional Paid-In Capital	2.06	2.01	0.67	0.49	0.52	-
Retained Earnings	-2.35	-3.14	-2.03	-1.01	-0.54	-0.03
Comprehensive Income & Other	2.11	2.11	-	-	-	-
Total Common Equity	52.77	51.92	30.34	2.27	2.72	0.97
Minority Interest	0.39	0.35	0.22	-	-	-
Shareholders' Equity	53.17	52.27	30.57	2.27	2.72	0.97
Total Liabilities & Equity	64.34	65.57	35.21	2.32	2.73	1

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4.43	4.55	0.95	-	-	-
Net Cash (Debt)	19.59	21.34	11.93	2.24	2.73	0.98
Net Cash Growth	125.53%	78.82%	432.33%	-17.99%	178.91%	-
Net Cash Per Share	0.13	0.17	0.15	0.11	0.14	0.06
Filing Date Shares Outstanding	174.08	174.08	117.3	20.28	20	16.17
Total Common Shares Outstanding	174.08	174.08	117.3	20.28	20	16.17
Working Capital	24.95	24.08	12.88	2.27	2.72	0.97
Book Value Per Share	0.30	0.30	0.26	0.11	0.14	0.06
Tangible Book Value	22.7	21.72	13.73	2.27	2.72	0.97
Tangible Book Value Per Share	0.13	0.12	0.12	0.11	0.14	0.06
Land	0.36	0.36	0.25	-	-	-
Buildings	3.7	3.7	2.85	-	-	-
Machinery	0.44	0.29	0.13	-	-	-
Leasehold Improvements	0.31	0.31	0.31	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error